Well before Covid-19 came on the scene, telehealth had earned its stripes as a cost-effective care delivery and population health platform.  Despite numerous benefits, telehealth’s potential was marginalized by the lobbying efforts of hospitals, medical associations, and specialists seeking to defend their turf and the lucrative nature of current fee-for-service payment models.  However, Covid-19 has prompted an unprecedented loosening of regulatory and reimbursement restrictions for telehealth-provided services.  With these moves, the telehealth genie is out of the bottle and promises to have an indelible, long-term impact on healthcare business models, health outcomes, and consumer expectations about healthcare convenience and access.